SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001213900-22-010753
Filing Date
2022-03-04
Accepted
2022-03-04 16:06:38
Documents
13

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT defr14a0222_helixacqcorp.htm DEFR14A 14170567
2 GRAPHIC tchart_001.jpg GRAPHIC 395294
3 GRAPHIC tchart_002.jpg GRAPHIC 470563
4 GRAPHIC tchart_003.jpg GRAPHIC 326372
5 GRAPHIC timage_005.jpg GRAPHIC 196165
6 GRAPHIC timage_004.jpg GRAPHIC 193389
7 GRAPHIC timage_006.jpg GRAPHIC 546734
8 GRAPHIC timage_007.jpg GRAPHIC 236620
9 GRAPHIC tchart_008.jpg GRAPHIC 464904
10 GRAPHIC tsvbleer_logo.jpg GRAPHIC 55371
11 GRAPHIC tsvbleer_footer.jpg GRAPHIC 111768
12 GRAPHIC tproxy_001.jpg GRAPHIC 1452215
13 GRAPHIC tproxy_002.jpg GRAPHIC 2397114
  Complete submission text file 0001213900-22-010753.txt   23603772
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116 857 702 0370
Helix Acquisition Corp (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-39630 | Film No.: 22714088
SIC: 2834 Pharmaceutical Preparations